Institut Curie Joins Co-Validation Study for Agendia’s MammaPrint, BluePrint Breast Cancer Kit
First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination.
Your email address will not be published.
Save my name, email, and website in this browser for the next time I comment.
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes